Shanghai Pulmonary Hospital, Shanghai, China: all 157 studies

Page 2 of 2. Open to participants first (94), then studies with results posted, then the rest; newest registration first within each.

• Toripalimab Combined With SBRT for NSCLCActive, not recruitingNCT06293690Phase 2
• Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and TreatmentStatus unknownNCT06086587
• CX3CR1+T Cell Predict Immunotherapy EfficacyCompletedNCT06054152
• Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 InfectionCompletedNCT05827328
• Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung AdenocarcinomaStatus unknownNCT05736991
• Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung CancerStatus unknownNCT05425134
• Clinical Characteristics of Lung Cancer in ChinaStatus unknownNCT05423236
• Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in AdultsStatus unknownNCT05313750Phase 4
• A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TBCompletedNCT05278988Phase 4
• Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for ThymectomyStatus unknownNCT05262582Not applicable
• Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04985201Phase 2
• a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung CancerStatus unknownNCT04790539Phase 2
• Application of Three-Dimensionally Printed Navigational Template in Lung BiopsyStatus unknownNCT04775901Not applicable
• Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung CancerCompletedNCT04702009Phase 2/3
• Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04698941Phase 2
• Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer PatientsStatus unknownNCT04696939Phase 2
• Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung CancerActive, not recruitingNCT04685070Phase 2
• Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial TumorStatus unknownNCT04667793Phase 2
• Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary NodulesStatus unknownNCT04554875
• Updated Severity and Prognosis Score of Pulmonary Alveolar ProteinosisCompletedNCT04516577
• Efficacy and Safety of An'Ningpai Expectorant in Non-CF BronchiectasisStatus unknownNCT04511897Phase 4
• Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue FluidStatus unknownNCT04511884
• Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow LimitationStatus unknownNCT04509661Phase 4
• Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population.Status unknownNCT04490447
• Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung CancerTerminatedNCT04422392Phase 2
• Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung CancerActive, not recruitingNCT04379739Phase 2
• Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLCStatus unknownNCT04372732
• Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLCStatus unknownNCT04360655Not applicable
• Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 InhibitorsStatus unknownNCT04355806
• Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer PlatformStatus unknownNCT04345939
• Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC PatientsStatus unknownNCT04229121
• Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer PatientsStatus unknownNCT04203095
• Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung AdenocarcinomaCompletedNCT04201756Phase 2
• Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung CancerStatus unknownNCT04156360
• Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene MutationStatus unknownNCT04137718
• Idiopathic Bronchiectasis and Pulmonary HypertensionCompletedNCT03883048
• NGS Combined With RNAseq on Tumor Immune Escape in NSCLCStatus unknownNCT03764917
• Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With ExacerbationCompletedNCT03643302
• Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic BronchiectasisCompletedNCT03643263
• Cytokine Profile of Allergic Bronchopulmonary AspergillosisStatus unknownNCT03643185
• Pilot Clinical Trial of PRS TB Regimen I - Phase IICompletedNCT03561753Phase 4
• Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
• Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility TrialCompletedNCT03325907Not applicable
• Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmonary Invasive Adenocarcinoma With Ground-glass OpacityStatus unknownNCT03322826Not applicable
• NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture StrategyStatus unknownNCT03224065Not applicable
• EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion PolymorphismStatus unknownNCT03002844Phase 2
• EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion PolymorphismStatus unknownNCT02859077Phase 3
• Corticosteroid Treatment for Acute Respiratory Distress SyndromeCompletedNCT02819453
• Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis BronchiectasisCompletedNCT02782312Phase 4
• Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With BronchiectasisStatus unknownNCT02546297Phase 4
• Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)Status unknownNCT02509364
• Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of BronchiectasisStatus unknownNCT02509091Phase 4
• Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis BronchiectasisStatus unknownNCT02507843Phase 4
• Research on New Regimens for Retreatment Pulmonary TuberculosisStatus unknownNCT02331823Phase 4
• The Role of KL-6 in the Clinical Diagnosis of ILDCompletedNCT02197364
• Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT02136992Phase 2
• Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.Status unknownNCT01983657Phase 2

← Shanghai Pulmonary Hospital, Shanghai, China overview and focus areas